Revance Therapeutics, Inc.

CIK 1479290 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Revance Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
May 15, 2025SCHEDULE 13G/A0000935836-25-000350
May 15, 2025SCHEDULE 13G/A0001076809-25-000060
Mar 6, 2025SCHEDULE 13G/A0000019617-25-000296
Feb 18, 202515-12G0001193125-25-028024
Feb 13, 2025SCHEDULE 13G/A0001306923-25-000009
Feb 12, 2025S-8 POS0001193125-25-024785
Feb 12, 2025POSASR0001193125-25-024783
Feb 12, 2025S-8 POS0001193125-25-024789
Feb 12, 2025S-8 POS0001193125-25-024799
Feb 12, 2025S-8 POS0001193125-25-024800
Feb 12, 2025S-8 POS0001193125-25-024801
Feb 12, 2025S-8 POS0001193125-25-024787
Feb 12, 2025S-8 POS0001193125-25-024804
Feb 12, 2025S-8 POS0001193125-25-024788
Feb 12, 2025S-8 POS0001193125-25-024792
Feb 12, 2025S-8 POS0001193125-25-024805
Feb 12, 2025S-8 POS0001193125-25-024802
Feb 12, 2025S-8 POS0001193125-25-024794
Feb 12, 2025S-8 POS0001193125-25-024786
Feb 12, 2025S-8 POS0001193125-25-024813
Feb 11, 2025SCHEDULE 13G0000019617-25-000200
Feb 6, 202540000950170-25-015362
Feb 6, 202540000950170-25-015361
Feb 6, 202540000950170-25-015322
Feb 6, 202540000950170-25-015341